Mbb Public Markets I »

Kyverna Therapeutics shares owned by Mbb Public Markets I

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Mbb Public Markets I from 13F filings

Historical chart of Mbb Public Markets I investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Mbb Public Markets I consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Mbb Public Markets I

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.1M 410k 7.50

More positions owned by Mbb Public Markets I

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
Teck Resources CL B (TECK)
Ishares Tr Msci India Etf (INDA)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Micron Technology (MU)
JPMorgan Chase & Co. (JPM)

View all positions for Mbb Public Markets I

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Bain Capital Life Sciences Investors
Northpond Ventures
Jpmorgan Chase & Co
Deerfield Management Company
Novo A/S
BlackRock
Vanguard Group
Millennium Management
Insight Holdings
Franklin Resources
T. Rowe Price Associates
Casdin Capital
Dr. Jeffrey R. Jay, M.D.
EcoR1 Capital

View all funds holding Kyverna Therapeutics